Q1 FY2027 saw modest sales growth and strong fund business gains, with robust leading indicators supporting a positive outlook for the year. Record-high transactions under negotiation and new mandates position the company to achieve its Vision 300 targets, while regulatory changes and AI adoption a…
Net sales grew slightly year-over-year, while operating and ordinary profit declined. Profit attributable to owners of parent and comprehensive income saw strong increases. The outlook projects moderate growth in sales and profit, with a special dividend planned.Original document: Nihon M&A Center…
Q1 FY2026 saw modest sales growth and a decline in ordinary profit due to fewer closed deals, but higher M&A sales per transaction and strong leading indicators support a positive outlook. Extraordinary gains from the fund business and robust new mandates position the company for continued growth.O…
